Nanjing Yuanshu Pharmaceutical Technology Co., Ltd. was established in 2015 and is located in the historical and cultural city of Nanjing. As a high-tech enterprise related to medicine and electronic materials, it has passed the national high-tech enterprise certification at the end of 2018 and won the honors of Jiangsu Private Technology Enterprise, ISO9001 International Quality Management System Certification Enterprise, Jiangsu Good Technology, etc. It was listed on the Science and Technology Innovation Board of Jiangsu Equity Exchange Center in 2020. Nanjing Yuanshu Pharmaceutical currently has a modern R&D center in Jiangsu Life Science and Technology Innovation Park in Nanjing, China, with complete international advanced instruments and equipment, management systems and functional departments. The company focuses on the CRO and CDMO business of clinical drug intermediates with high synthetic difficulty and the development of ADC drugs. The R&D team has a professional process development team and follows a strict confidentiality system and intellectual property protection system for customer customized projects. At present, 21 authorized invention patents have been obtained, 5 patents are pending review, and 11 invention patents have been accepted. The company's philosophy is to insist that technological innovation is the driving force for corporate development! We will strive to become a professional manufacturer and supplier in the field of medicine and materials.